Dynaglipt-M Tablet SR (Metformin/Teneligliptin) for Type 2 Diabetes is a dual-therapy medicine designed to control high blood sugar in adults with Type 2 Diabetes Mellitus. By combining Metformin (which reduces liver glucose production) and Teneligliptin (which improves incretin action), this medicine helps maintain stable sugar levels. It is widely prescribed for diabetes management, as confirmed by trusted resources like Mayo Clinic and Drugs.com. For more information on other diabetes medicines, visit our Diabetes Care section or check our Metformin guide.
Key Benefits & Uses of Dynaglipt-M Tablet SR
-
Effective control of Type 2 Diabetes blood sugar levels
-
Improves insulin sensitivity and reduces sugar absorption
-
Reduces risk of diabetic complications (kidney, nerve, and eye damage) – WebMD reference
-
Backed by research and clinical trials on PubMed
-
Sustained-release formula for longer-lasting blood sugar control
How to Use Dynaglipt-M Tablet SR (Metformin/Teneligliptin)
-
Take the tablet once or twice daily with meals
-
Swallow whole; do not crush or chew the sustained-release form
-
Follow your doctor’s prescription and refer to FDA or Healthline for usage guidelines
-
You can also read our How to Take Diabetes Medicines Guide for more details
Important Safety Information
-
Avoid use in patients with kidney, liver, or heart disease
-
Do not consume alcohol, as it increases risk of lactic acidosis
-
Pregnant or breastfeeding women must consult a doctor
-
Read updates from WHO on safe diabetes treatment practices
Common Side Effects of Dynaglipt-M Tablet SR
-
Mild nausea, vomiting, or diarrhea
-
Headache and dizziness
-
Low blood sugar (rare, usually when combined with other medicines)
For a detailed list, see Drugs.com
Why Choose Dynaglipt-M Tablet SR (Metformin/Teneligliptin)?
-
Dual action formula for superior Type 2 Diabetes management
-
Recommended by doctors worldwide
-
Backed by scientific research and global health organizations
-
Long-lasting sustained-release benefit for better compliance

